How much is Vivace Therapeutics worth in 2026?

Vivace Therapeutics has a current valuation of $125.0M based on their Later Stage VC round and secondary market data.

How much funding has Vivace Therapeutics raised?

Vivace Therapeutics has raised $105.0M in total funding across 1 funding rounds.

Vivace Therapeutics

Drug DiscoveryWebsite

Vivace Therapeutics valuation and funding history | Last updated: February 28, 2025 | 1 funding rounds

Current Valuation

$125.0M

As of February 28, 2025

Total Funding Raised

$105.0M

Across 1 round

Last Round

Later Stage VC

$35.0M

Last Funding

Feb 2025

Funding date

Capital Efficiency

1.19x

Valuation / Funding

Funding History & Valuation Timeline

Complete history of all funding rounds and valuation milestones

Date	Round	Amount	Post-Valuation	Growth
February 28, 2025	Later Stage VC (Series D)	$35.0M	N/A	-

Valuation Analysis

Current Valuation Metrics

Vivace Therapeutics is currently valued at $125.0M as of February 28, 2025. The company has raised a total of $105.0M in funding across 1 funding round.

Capital Efficiency

With a capital efficiency ratio of 1.19x, Vivace Therapeutics has achieved a valuation that is 1.19 times the total capital raised.

Track Vivace Therapeutics Valuation Updates

Get notified when Vivace Therapeutics raises new funding or valuation changes

Explore More Data

Detailed analysis for Vivace Therapeutics

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

View 5 companies free

Create a free account to unlock Vivace Therapeutics's valuation history, funding rounds, and growth metrics.

No credit card required

What is Vivace Therapeutics Worth in 2026?

Vivace Therapeutics is a leading private company in the Drug Discovery sector. Track Vivace Therapeutics's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.

How Vivace Therapeutics Valuation is Determined

Private company valuations like Vivace Therapeutics's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.